#United States #Morrisville #LED Technology #Revian #Amy Keish

REVIAN Inc. Appoints Amy Keish as Senior Vice President of Sales

REVIAN Inc., a frontrunner in aesthetic medical technology, has announced the elevation of Amy Keish to the role of Senior Vice President of Sales. This strategic move is aimed at further accelerating the company’s growth trajectory in the U.S. and international markets.

With over 20 years of experience in aesthetics sales, Amy Keish has been a cornerstone in the advancement of REVIAN’s commercial strategy. She has been instrumental in expanding the company's physician-driven sales organization, fostering significant collaborations across various domains such as dermatology and aesthetics. Keish will maintain her focus on national sales strategy, field operations, and enhancing partner relations, all vital for REVIAN's ambitious growth objectives.

John Oakley, the CEO of REVIAN, praised Keish’s contributions, stating, "Amy has been crucial in establishing a disciplined and high-performing sales team that aligns with the requirements of our physician partners. Her operational strength and extensive knowledge of the aesthetic medical landscape have been pivotal in our growth. This promotion acknowledges her essential role and the vast possibilities ahead for REVIAN."

Keish's leadership has led to a notable expansion of REVIAN’s footprint nationwide, establishing the company as a reliable, science-oriented ally for physicians in the aesthetics field. "REVIAN is at an exhilarating juncture," remarked Keish. "I am proud of our team's accomplishments and invigorated by the prospect of scaling effectively while venturing into new markets."

This announcement comes on the heels of consistent growth for REVIAN, fueled by a growing acceptance of its dual-wavelength LED technology among physicians and ongoing investments in its commercial infrastructure. CE marked, REVIAN's technology leverages patented combinations of light wavelengths to invigorate nitric oxide production, which is scientifically proven to enhance local blood circulation, diminish inflammation, and obstruct DHT production. This functionality creates an optimal environment conducive to new hair growth.

REVIAN's products are specifically indicated for treating androgenetic alopecia in both males and females, effectively promoting hair growth amidst various patterns of hair loss. The company’s commitment to providing effective, science-backed solutions allows patients to experience aesthetic enhancements in their own homes, illustrating the balance of innovation and practicality that defines REVIAN’s mission.

As Keish steps into this new role, she is set to harness her extensive background in sales leadership to propel REVIAN’s market presence. With a keen interest in furthering partnerships and refining the company's sales tactics, her leadership promises to steer REVIAN toward substantial achievements in the aesthetics sphere.

About REVIAN Inc.

REVIAN is a subsidiary of KNOW Bio, LLC, dedicated to enhancing natural rejuvenation processes in hair and skin through advanced light therapies. Through well-researched products tailored for home use, REVIAN seeks to empower healthcare professionals and clients alike, promising meaningful results supported by scientific evidence. For more detailed information, visit www.revian.com.